Search
for
Sort by
Research 31–60 of 280
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Roles of steroid receptors in the lung and COVID-19
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- COVID‐19, androgens, and androgenic alopecia
- Cutaneous signs in COVID ‐19 patients: A review
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- Editor’s picks January 2021
- The Mask Mutation Identifies TMPRSS6 as an Essential Suppressor of Hepcidin Gene Expression, Required for Normal Uptake of Dietary Iron.
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- COVID-19 Severity and Androgen Receptor Polymorphism
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Structural perspectives on the androgen receptor, the elusive shape-shifter
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Polymorphism of genes in patients with new coronavirus infection COVID-19
- Vitamin D And Tmprss2: Intersecting Pathways In Post-Covid-19 Alopecia
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19